Research, Charts & Company Announcements
Research Tree provides access to ongoing research coverage, media content and regulatory news on GOOCH & HOUSEGO PLC. We currently have 39 research reports from 3 professional analysts.
|07Dec16 07:00||RNS||Posting of Annual Report and AGM Notice|
|29Nov16 07:00||RNS||Preliminary Results|
|05Oct16 07:00||RNS||Full Year Trading Update|
|28Sep16 03:20||RNS||Holding(s) in Company|
|09Aug16 12:54||RNS||Holding(s) in Company|
|05Aug16 10:35||RNS||Holding(s) in Company|
Frequency of research reports
Research reports on
GOOCH & HOUSEGO PLC
GOOCH & HOUSEGO PLC
19 Dec 16
600 GROUP | ACCSYS TECHNOLOGIES | AGGREGATED MICRO POWER HLDGS PLC | ALUMASC GROUP | ANGLO-EASTERN PLANTATIONS | AVINGTRANS PLC | CAPITAL DRILLING LTD | CARCLO | FENNER PLC | FLOWTECH FLUIDPOWER PLC | GLOBAL INVACOM GROUP LTD | GOOCH & HOUSEGO PLC | HARDIDE PLC | HAYWARD TYLER GROUP PLC | IOFINA PLC | M.P.EVANS GROUP | R.E.A. HLDGS PLC | REDT ENERGY PLC | RENOLD | ROBINSON | SOMERO ENTERPRISE INC | SURFACE TRANSFORMS PLC | TRANSENSE TECHNOLOGIES PLC | TRIFAST | ZAMBEEF PRODUCTS
Results ahead of expectations, with a strong start to the current year
29 Nov 16
FY results were £0.5m ahead of our expectations, with a particularly strong final few months of trading and currency tailwind. The record order book helps underpin forecast sales growth, with production growth helped by capacity expansion. No change to forecasts, but with forecast risk on the upside we raise our target price to 1050p, giving modest upside in the shares. The company’s conservative approach to guidance, coupled with an upbeat trading outlook provides scope for further appreciation.
N+1 Singer - Gooch & Housego - Good FY16 growth, forecast to increase in FY17
29 Nov 16
Gooch & Housego reported good growth for FY16, with adjusted PBT up 10%, a little ahead of our estimates. Positive momentum has continued into FY17, supported by a record order book which was up 45% at the year end. Our headline profit forecasts are largely unchanged, although there is potential for upgrades later in the year if current FX rates are maintained and/or further M&A is announced, leveraging G&H’s strong balance sheet. We retain our Buy recommendation.
N+1 Singer - Gooch & Housego - FY16 trading in line with expectations
05 Oct 16
Gooch & Housego has confirmed trading for FY16 in line with expectations. The group is well-positioned for further growth in FY17, supported by strong growth in its year end order book to £52.8m (54% of our FY17 sales forecast) and by cross-selling opportunities from its recent acquisitions. Longer term prospects remain positive reflecting the group’s specialist photonics expertise, its continued focus on diversification to drive growth and improve the resilience of its portfolio, and its progress up the value chain. The shares have drifted off over the last two weeks, enabling us to reiterate our Buy recommendation.
The Slide Rule
12 Jan 17
What is The Slide Rule? The Slide Rule has been designed to dramatically simplify the identification of the best companies in the UK small/mid-cap sector by making a quantitative assessment of the relative potential of each company. At its core, The Slide Rule aims to identify those companies that create genuine shareholder value through strong returns on capital and solid growth, but also present a value opportunity with the potential tailwind of earnings momentum. Companies are assessed within a Quality, Value, Growth and Momentum (QVGM) framework.
16 Jan 17
We take a look at the rankings of the various countries in Africa that have a significant exposure to mining. We take the Transparency International corruption rankings as our starting point and modify these for exceptional geology and for current UK government travel warnings. Ghana, Botswana and Namibia come out as our top three, with Eritrea, Kenya and Zimbabwe at the bottom of our rankings.
19 Jan 17
Aggregated Micro Power* (AMPH): Funding for first peaking power plant project (CORP) | The Mission Marketing Group* (TMMG): Positive trading update (CORP) | Cello (CLL): Increasingly backed by, and leveraging, technology (BUY) | 4imprint (FOUR): Growth backed by strong cash flow continues (BUY) | Allergy Therapeutics (AGY): Positive trading update and market share gains drive upgrades (BUY) | Shanta Gold (SHG): Q4 operating results (BUY) | Sound Energy (SOU): Tendrara extended well test result (BUY) | Revolution Bars (RBG): Price target increase (BUY)
Small Cap Breakfast
17 Jan 17
Global Energy Development (GED.L) — To be renamed Nautilus Marine Services. Schedule 1 from developer and seller of hydrocarbons and related products. Reverse takeover. Raising $10.5m via a convertible. Expected 9 Feb. Eco (Atlantic) Oil & Gas—TSX-V listed oil and gas exploration has announced its intention to float on AIM. Assets in Guyana and Namibia. Proposed £2m-£3m fundraise. Diversified Gas & Oil—According to LSE website first day of trading on AIM now expected for 30 January.
N+1 Singer - St Ives - Downgrade
19 Jan 17
Marketing activation has been impacted by further decline in grocery retail impacting profit by c£5m. Strategic The Company is also taking this opportunity to revise its guidance for Strategic Marketing as its recovery pace is not running at the planned target rate. PBT falls from N1Se £31.9m to £25m. The Company expects dividend to be held based upon lowered guidance and the implied cash flow performance. There do not appear to be any covenant issues. Forecasts and TP under review and downgrade to Hold. We expect the shares to test the 100p level.
N+1 Singer - Northern lights - Shining prospects for 2017
16 Jan 17
As the birthplace of Stephenson, Armstrong and Swan, the North East of England has a proud history of industrial and technological innovation. Despite local economic challenges, the region’s industrial heritage lives on through continuing success in high end engineering and technology. The recent takeovers of private equity backed SMD (subsea robotics) and Nomad Digital (wi-fi on the railways) are testament to this. The North East has also emerged as a leader in genetics and genomics with an enviable life sciences and healthcare infrastructure. Against this backdrop, we expect the region to continue to throw up attractive IPO candidates to build on the six new listings in the past three years. We expect 2017 to be far kinder to the existing portfolio of North East plcs than 2016 (a year to forget) with recent management changes one important theme for the new year. Our top picks are Hargreaves Services, Quantum Pharma and Zytronic (all N+1 Singer Corporate clients) and we are Buyers of Northgate and Grainger.